| Application of chemoproteomics to drug discovery: identification of a clinical candidate targeting hsp90. Fadden P., Huang K.H., Veal J.M., Steed P.M., Barabasz A.F., Foley B., Hu M., Partridge J.M., Rice J., Scott A. et al.
Chem. Biol. 17:686-694(2010) · Mapped (1) |
| Inactivation of TNF signaling by rationally designed dominant-negative TNF variants. Steed P.M., Tansey M.G., Zalevsky J., Zhukovsky E.A., Desjarlais J.R., Szymkowski D.E., Abbott C., Carmichael D., Chan C., Cherry L. et al.
Science 301:1895-1898(2003) |
| Presence of cathepsin B in the human pancreatic secretory pathway and its role in trypsinogen activation during hereditary pancreatitis. Kukor Z., Mayerle J., Kruger B., Toth M., Steed P.M., Halangk W., Lerch M.M., Sahin-Toth M.
J. Biol. Chem. 277:21389-21396(2002) · Mapped (24) |
| Characterization of human PLD2 and the analysis of PLD isoform splice variants. Steed P.M., Clark K.L., Boyar W.C., Lasala D.J.
FASEB J. 12:1309-1317(1998) · UniProtKB (2) |
| Use of the rep technique for allele replacement to construct mutants with deletions of the pstSCAB-phoU operon: evidence of a new role for the PhoU protein in the phosphate regulon. Steed P.M., Wanner B.L.
J. Bacteriol. 175:6797-6809(1993) · UniProtKB (1) |
| Identification of phosphate starvation-inducible genes in Escherichia coli K-12 by DNA sequence analysis of psi::lacZ(Mu d1) transcriptional fusions. Metcalf W.W., Steed P.M., Wanner B.L.
J. Bacteriol. 172:3191-3200(1990) · UniProtKB (6) · Mapped (1) |
